Level Four Advisory Services’s Viking Therapeutics VKTX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q2
Sell
-8,327
Closed -$201K 816
2025
Q1
$201K Buy
8,327
+925
+12% +$29.2K 0.01% 719
2024
Q4
$298K Buy
7,402
+174
+2% +$9.92K 0.01% 628
2024
Q3
$524K Sell
7,228
-5,206
-42% -$305K 0.02% 497
2024
Q2
$659K Sell
12,434
-19,762
-61% -$1.3M 0.03% 422
2024
Q1
$599K Buy
32,196
+822
+3% +$36.6K 0.03% 420
2023
Q4
$584K Buy
31,374
+14,638
+87% +$191K 0.03% 424
2023
Q3
$185K Sell
16,736
-34,206
-67% -$489K 0.01% 691
2023
Q2
$826K Buy
50,942
+39,342
+339% +$824K 0.05% 333
2023
Q1
$193K Buy
+11,600
New +$120K 0.01% 702

Other funds holding VKTX